Company · mentioned 32 times
AI drug discovery company based in London, spun out of Google DeepMind and backed by Alphabet, focused on designing new medicines using artificial intelligence.
Tap a name to go there · tap a line to see why they are linked
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch· 15 Oct
Rory O'Driscoll argues Isomorphic captures value by making discoveries, with a 10% royalty on a $200 billion drug.Invest Like the Best with Patrick O'Shaughnessy· 18 Feb
After AlphaFold came out, Josh Kushner told Demis Hassabis he would be excited to support Isomorphic.